Organon & Co. ( OGN) - Key Metrics
OGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.93 | $0.41 | $0.41 | $0.25 |
| 2026Q1 | $5.61 | $0.56 | $0.86 | $0.72 |
| 2025Q4 | $5.79 | -$0.79 | $0.54 | $0.37 |
| 2025Q3 | $6.16 | $0.62 | $1.02 | $0.57 |
| 2025Q2 | $6.13 | $0.56 | $0.85 | $0.70 |
OGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 5.56% | 8.26 |
| 2026Q1 | 3.42% | 2.72 |
| 2025Q4 | -1.95% | -2.27 |
| 2025Q3 | 1.87% | 4.31 |
| 2025Q2 | 6.90% | 4.32 |
OGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.83% | 0.17% |
| 2026Q1 | 12.05% | 0.32% |
| 2025Q4 | 5.15% | 0.21% |
| 2025Q3 | 5.37% | 0.11% |
| 2025Q2 | 7.19% | 0.40% |
OGN
Price: $13.76
Dividend Yield: 0.58%
Forward Dividend Yield: 0.58%
Payout Ratio: 28.87%
Dividend Per Share: 0.08 USD
Earnings Per Share: 0.78 USD
P/E Ratio: 17.59
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 1.6 million
Market Capitalization: 3.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 6
DGR3: -15.48%